Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
311,298
-
Share change
-
+27,680
-
Total reported value
-
$891,000
-
Price per share
-
$2.86
-
Number of holders
-
15
-
Value change
-
-$9,852
-
Number of buys
-
8
-
Number of sells
-
7
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q2 2021
As of 30 Jun 2021 Scinai Immunotherapeutics Ltd. - ADSs (BVXV) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 311,298 shares of stock of the company.
Largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, MORGAN STANLEY, HRT FINANCIAL LP, TRUE Private Wealth Advisors, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Advisory Services Network, LLC, CREDIT AGRICOLE S A, and ROYAL BANK OF CANADA.
This table shows 15 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.